XBI
HealthcareState Street SPDR S&P Biotech ETF
State Street · Tracks S&P Biotechnology Select Industry Index · Inception Jan 31, 2006
Expense ratio
0.35%
35.0 bps
Net assets
$8.30B
TTM yield
0.34%
Last price
$131.71
as of May 20, 2026
Composite score
79 / 100
Cost 65
Based on a 0.35% expense ratio.
Liquidity 96
Based on $8.30B in net assets.
Concentration N/A
No holdings data available — N-PORT not filed or fund is not a 1940-Act registrant.
Tax efficiency 84
Healthcare base · ETF wrapper · 0.34% TTM yield.
Tracking quality N/A
Planned for a future methodology version. Not yet computed.
Scores reflect available inputs only. The composite is a weighted average over present sub-scores; weights renormalize when components are unavailable. See methodology for formulas (methodology v0.3.0).
Top holdings
No holdings data available for this fund.
Compare XBI with another fund
Or skim the closest-overlap funds below.